Valuation: Farmacias Benavides, S.A.B. de C.V.

Market Cap 10.22B 588M 514M 474M 436M 826M 56.56B 840M 5.66B 2.22B 27.65B 2.21B 2.16B 95.29B P/E 2024
68.9x
P/E 2025 47.4x
Enterprise Value 11.96B 688M 601M 555M 510M 966M 66.16B 982M 6.62B 2.6B 32.34B 2.58B 2.53B 111B EV / Sales 2024
0.69x
EV / Sales 2025 0.64x
Free-Float
16.07%
Yield 2024 *
-
Yield 2025 -
05-26 Mexico's Farmacias Benavides starts process to delist from official securities registry RE
04-30 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02-26 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
25-10-28 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-07-28 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-04-29 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-02-26 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
24-08-15 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-05-13 Farmacias Benavides, S.A.B. de C.V. Auditor Raises 'Going Concern' Doubt CI
24-04-25 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-02-26 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
23-10-27 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
23-07-28 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Manager TitleAgeSince
Chief Executive Officer - 2024-12-01
Director of Finance/CFO - 2026-03-16
Director of Finance/CFO - -
Director TitleAgeSince
Chairman - 2023-05-01
Director/Board Member - 2020-12-31
Director/Board Member - 2023-05-01
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 587M
-1.97%+0.26%+0.52%+7.68% 6.61B
-0.10%-9.67%-18.55%+42.62% 3.32B
-4.78%-7.51%-29.52%-19.85% 3.21B
-0.76%-2.41%-15.49%-8.26% 2.77B
+0.91%-4.40%-3.35%+44.49% 2.2B
+0.59%+1.94%+4.60%-1.73% 1.35B
+3.27%+8.35%-35.61%-42.18% 1.34B
-0.87%+0.59%+20.95%+56.83% 473M
+0.78%+1.96%-38.66%-69.08% 361M
Average -0.29%-0.39%-12.79%+1.17% 2.4B
Weighted average by Cap. -1.07%-1.23%-11.49%+6.77%

Financials

2024 2025
Net sales 17.65B 1.01B 887M 819M 752M 1.43B 97.65B 1.45B 9.77B 3.83B 47.73B 3.81B 3.73B 165B 19.46B 1.12B 978M 903M 830M 1.57B 108B 1.6B 10.78B 4.23B 52.63B 4.2B 4.11B 181B
Net income 131M 7.51M 6.56M 6.05M 5.57M 10.55M 722M 10.73M 72.28M 28.36M 353M 28.19M 27.57M 1.22B 224M 12.89M 11.27M 10.39M 9.56M 18.11M 1.24B 18.42M 124M 48.69M 606M 48.4M 47.34M 2.09B
Net Debt 3.26B 187M 164M 151M 139M 263M 18.04B 268M 1.81B 708M 8.82B 704M 689M 30.39B 1.73B 99.76M 87.22M 80.46M 73.96M 140M 9.6B 143M 961M 377M 4.69B 375M 366M 16.17B
Logo Farmacias Benavides, S.A.B. de C.V.
Farmacias Benavides SAB de CV is a Mexico-based company primarily engaged in the pharmaceutical and chemical industry. The Company operates a network of over 700 drug stores located nationwide under the Farmacias Benavides name. Through its network of drug stores, it sells a variety prescription and over the counter (OTC) medicines, cosmetics, personal and baby care products and toiletries, as well as it also provides such related services as laboratory samples, home delivery, prescription laboratory, online pharmacy and photo processing services. As of December 31, 2011, the Company owned such subsidiaries as Servicios Operacionales Benavides SA de CV, Benavides de Reynosa SA de CV and Servicios Logisticos Benavides SA de CV, and Fasa Investment Limitada which was its majority shareholder with 85.25% of its interest.
Employees
-